$3.41
-0.07-2.01%
Last update: Nov 10, 7:59 PM
Wave Life Sciences Inc
WVENASDAQ
Wave Life Sciences fell 50.6% from $7.05 to $3.48, behind the S&P 500's +10.0%. Its worst day was Mar 26 (−49.6%), and its low came Oct 14 at $3.09.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.32 missed the $-0.30 estimate on $7.6M revenue (est. $11.5M).
0.0% · S&P 500 +1.6%
Wave Life Sciences closed at its highest level of the year, 202.3% above where the year started.
Story events cover the past 12 months · Times ET
+15.1% · S&P 500 −0.1%
EPS of $-0.30 missed the $-0.27 estimate on $17.2M revenue (est. $14.2M).
+5.6% · S&P 500 −0.6%
Wave Life Sciences shares fell 49.6%, while the S&P 500 fell 1.8%.
−49.6%, the year's worst day · S&P 500 −1.8%
EPS of $-0.13 beat the $-0.32 estimate on $38.2M revenue (est. $8.5M).
+8.4% · S&P 500 −0.5%
EPS of $-0.34 missed the $-0.30 estimate on $2.3M revenue (est. $7.4M).
−0.9% · S&P 500 +1.7%
Wave Life Sciences closed at its lowest level of the year, 56.2% below where the year started.
−1.6% · S&P 500 −1.1%
EPS of $-0.30 beat the $-0.33 estimate on $13.2M revenue (est. $4.1M).
+7.5% · S&P 500 +0.6%
Where it ended: a close of $3.48 on Nov 9, 2026. Up next: Q4 2026 earnings on Feb 25, 2027 (EPS est. $-0.33, revenue est. $8.7M).
Nothing in the past 12 months.
All WVE dividend historyReplay the year: the line draws itself and stops at each of the 8 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for WVE and SPY from Benzinga historical bars. Not investment advice.
